Throughout this medical market research, the publisher analyzed 22 dental bone graft substitutes companies in Japan and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this MedSuite report contains all of the Japanese Dental Bone Graft Substitutes Market analysis, each of the market segments is also available for purchase as a stand-alone report, MedCore.
Markets Covered
Japanese Dental Bone Graft Substitutes Market Insights
Overall, the Japan dental bone graft substitutes and other biomaterials market was valued at $9.6 million in 2020. This is expected to increase over the forecast period at a CAGR of 20.3% to reach $34.8 million. in 2027.
An ongoing trend within the market for dental biomaterials is the increasing market share of xenograft materials. In Japan, synthetic materials make up the majority of dental biomaterials sold; however, it is expected that they will lose some market share to xenograft materials over the forecast period.
GC Corporation commanded the leading share of the DBGS market. This is a result of the company’s significant share of the synthetic DBGS market. The company will continue to face competition from HOYA Technosurgical and other companies in the increasingly crowded synthetic space.
While this MedSuite report contains all of the Japanese Dental Bone Graft Substitutes Market analysis, each of the market segments is also available for purchase as a stand-alone report, MedCore.
Markets Covered
- Dental Bone Graft Substitutes Market - MedCore
- Dental Barrier Membranes Market - MedCore
Japanese Dental Bone Graft Substitutes Market Insights
Overall, the Japan dental bone graft substitutes and other biomaterials market was valued at $9.6 million in 2020. This is expected to increase over the forecast period at a CAGR of 20.3% to reach $34.8 million. in 2027.
An ongoing trend within the market for dental biomaterials is the increasing market share of xenograft materials. In Japan, synthetic materials make up the majority of dental biomaterials sold; however, it is expected that they will lose some market share to xenograft materials over the forecast period.
GC Corporation commanded the leading share of the DBGS market. This is a result of the company’s significant share of the synthetic DBGS market. The company will continue to face competition from HOYA Technosurgical and other companies in the increasingly crowded synthetic space.
Table of Contents
Table of ContentsList of FiguresList of ChartsExecutive SummaryJapan Dental Bone Graft Substitute and Other Biomaterials Market OverviewCompetitive AnalysisMarket TrendsMarket DevelopmentsMarkets IncludedVersion HistoryAbbreviations
Research Methodology
Impact of COVID-19 on the Japan Dental Bone Graft Substitute and Other Biomaterials Market
Disease Overview
Product Assessment
Japan Dental Bone Graft Substitute and Other Biomaterials Market Overview
Dental Bone Graft Substitute Market
Dental Barrier Membrane Market
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Botiss Biomaterials
- Citagenix
- CoorsTek
- Curasan
- Datum Dental
- Envista
- GC Corporation
- Geistlich
- Genoss
- HOYA Technosurgical
- Impladent
- J. Morita
- Koken
- KYOCERA
- Terumo
- Osteogenics
- Unicare Biomedical
- Zimmer Biomet
